Le SIDA en Afrique subsaharienne (serveur d'exploration)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
***** Acces problem to record *****\

Identifieur interne : 0019469 ( Pmc/Corpus ); précédent : 0019468; suivant : 0019470 ***** probable Xml problem with record *****

Links to Exploration step


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">EFFECT OF DEPOT MEDOXYPROGESTERONE ACETATE ON IMMUNE FUNCTIONS AND INFLAMMATORY MARKERS OF HIV-INFECTED WOMEN</title>
<author>
<name sortKey="Weinberg, Adriana" sort="Weinberg, Adriana" uniqKey="Weinberg A" first="Adriana" last="Weinberg">Adriana Weinberg</name>
<affiliation>
<nlm:aff id="A1">University of Colorado Denver Anschutz Medical Center, Aurora, CO</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Park, Jeong Gun" sort="Park, Jeong Gun" uniqKey="Park J" first="Jeong-Gun" last="Park">Jeong-Gun Park</name>
<affiliation>
<nlm:aff id="A2">Statistical and Data Analysis Center, Harvard School of Public Health, Boston, MA</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Bosch, Ronald" sort="Bosch, Ronald" uniqKey="Bosch R" first="Ronald" last="Bosch">Ronald Bosch</name>
<affiliation>
<nlm:aff id="A2">Statistical and Data Analysis Center, Harvard School of Public Health, Boston, MA</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Cho, Alice" sort="Cho, Alice" uniqKey="Cho A" first="Alice" last="Cho">Alice Cho</name>
<affiliation>
<nlm:aff id="A1">University of Colorado Denver Anschutz Medical Center, Aurora, CO</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Livingston, Elizabeth" sort="Livingston, Elizabeth" uniqKey="Livingston E" first="Elizabeth" last="Livingston">Elizabeth Livingston</name>
<affiliation>
<nlm:aff id="A3">Duke University Medical Center, Durham, NC</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Aweeka, Fran" sort="Aweeka, Fran" uniqKey="Aweeka F" first="Fran" last="Aweeka">Fran Aweeka</name>
<affiliation>
<nlm:aff id="A4">University of California, San Francisco, CA</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Cramer, Yoninah" sort="Cramer, Yoninah" uniqKey="Cramer Y" first="Yoninah" last="Cramer">Yoninah Cramer</name>
<affiliation>
<nlm:aff id="A2">Statistical and Data Analysis Center, Harvard School of Public Health, Boston, MA</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Watts, D Heather" sort="Watts, D Heather" uniqKey="Watts D" first="D. Heather" last="Watts">D. Heather Watts</name>
<affiliation>
<nlm:aff id="A5">Office of the Global AIDS Coordinator and Health Diplomacy, U.S. Department of State, Washington, DC</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Luque, Amneris E" sort="Luque, Amneris E" uniqKey="Luque A" first="Amneris E." last="Luque">Amneris E. Luque</name>
<affiliation>
<nlm:aff id="A6">University of Rochester School of Medicine and Dentistry, Rochester, NY</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Cohn, Susan E" sort="Cohn, Susan E" uniqKey="Cohn S" first="Susan E." last="Cohn">Susan E. Cohn</name>
<affiliation>
<nlm:aff id="A7">Northwestern University Feinberg School of Medicine, Chicago, IL</nlm:aff>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PMC</idno>
<idno type="pmid">26413850</idno>
<idno type="pmc">4712075</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4712075</idno>
<idno type="RBID">PMC:4712075</idno>
<idno type="doi">10.1097/QAI.0000000000000850</idno>
<date when="2016">2016</date>
<idno type="wicri:Area/Pmc/Corpus">001946</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">001946</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a" type="main">EFFECT OF DEPOT MEDOXYPROGESTERONE ACETATE ON IMMUNE FUNCTIONS AND INFLAMMATORY MARKERS OF HIV-INFECTED WOMEN</title>
<author>
<name sortKey="Weinberg, Adriana" sort="Weinberg, Adriana" uniqKey="Weinberg A" first="Adriana" last="Weinberg">Adriana Weinberg</name>
<affiliation>
<nlm:aff id="A1">University of Colorado Denver Anschutz Medical Center, Aurora, CO</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Park, Jeong Gun" sort="Park, Jeong Gun" uniqKey="Park J" first="Jeong-Gun" last="Park">Jeong-Gun Park</name>
<affiliation>
<nlm:aff id="A2">Statistical and Data Analysis Center, Harvard School of Public Health, Boston, MA</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Bosch, Ronald" sort="Bosch, Ronald" uniqKey="Bosch R" first="Ronald" last="Bosch">Ronald Bosch</name>
<affiliation>
<nlm:aff id="A2">Statistical and Data Analysis Center, Harvard School of Public Health, Boston, MA</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Cho, Alice" sort="Cho, Alice" uniqKey="Cho A" first="Alice" last="Cho">Alice Cho</name>
<affiliation>
<nlm:aff id="A1">University of Colorado Denver Anschutz Medical Center, Aurora, CO</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Livingston, Elizabeth" sort="Livingston, Elizabeth" uniqKey="Livingston E" first="Elizabeth" last="Livingston">Elizabeth Livingston</name>
<affiliation>
<nlm:aff id="A3">Duke University Medical Center, Durham, NC</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Aweeka, Fran" sort="Aweeka, Fran" uniqKey="Aweeka F" first="Fran" last="Aweeka">Fran Aweeka</name>
<affiliation>
<nlm:aff id="A4">University of California, San Francisco, CA</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Cramer, Yoninah" sort="Cramer, Yoninah" uniqKey="Cramer Y" first="Yoninah" last="Cramer">Yoninah Cramer</name>
<affiliation>
<nlm:aff id="A2">Statistical and Data Analysis Center, Harvard School of Public Health, Boston, MA</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Watts, D Heather" sort="Watts, D Heather" uniqKey="Watts D" first="D. Heather" last="Watts">D. Heather Watts</name>
<affiliation>
<nlm:aff id="A5">Office of the Global AIDS Coordinator and Health Diplomacy, U.S. Department of State, Washington, DC</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Luque, Amneris E" sort="Luque, Amneris E" uniqKey="Luque A" first="Amneris E." last="Luque">Amneris E. Luque</name>
<affiliation>
<nlm:aff id="A6">University of Rochester School of Medicine and Dentistry, Rochester, NY</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Cohn, Susan E" sort="Cohn, Susan E" uniqKey="Cohn S" first="Susan E." last="Cohn">Susan E. Cohn</name>
<affiliation>
<nlm:aff id="A7">Northwestern University Feinberg School of Medicine, Chicago, IL</nlm:aff>
</affiliation>
</author>
</analytic>
<series>
<title level="j">Journal of acquired immune deficiency syndromes (1999)</title>
<idno type="ISSN">1525-4135</idno>
<idno type="eISSN">1944-7884</idno>
<imprint>
<date when="2016">2016</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass></textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">
<sec id="S1">
<title>Objectives</title>
<p id="P1">Depot medroxyprogesterone acetate (DMPA) was associated with increased HIV transmission and accelerated disease progression in untreated women. The potential underlying mechanisms include immune-modulation. We evaluated the effect of a single DMPA injection on cell-mediated immunity (CMI), T cell activation (Tact), regulation (Treg) and inflammation in HIV-infected women on cART.</p>
</sec>
<sec id="S2">
<title>Methods</title>
<p id="P2">Women with HIV plasma RNA ≤400 c/mL on stable cART received DMPA and had immunologic and MPA measurements at baseline, 4 weeks [peak MPA concentration (Cmax)] and 12 weeks [highest MPA area under the concentration curve (AUC)].</p>
</sec>
<sec id="S3">
<title>Results</title>
<p id="P3">At baseline, among 24 women with median 32 years of age and 622 CD4+ cells/μL, ≥68% had HIV, VZV, PHA and CD3/CD28 CMI measured by lymphocyte proliferation and/or IFNγ/IL2 dual-color fluorospot. CMI did not significantly change after DMPA administration except for a 1.4-fold increase in IL2/IFNγ VZV fluorospot at week 12. Tact decreased after DMPA administration, reaching statistical significance at week 12 for CD4+CD25+%. Treg behaved heterogeneously with an increase in CD8+FOXP3+% at week 4 and a decrease in CD4+IL35+% at week 12. There was a decrease in TGFβ at week 12 and no other changes in plasma biomarkers. Correlation analyses showed that high MPA Cmax and/or AUC were significantly associated with increases of IFNγ HIV ELISPOT, CD4+IL35+% and CD4+TGFβ+% Treg and decreases of plasma IL10 from baseline to weeks 4 and/or 12.</p>
</sec>
<sec id="S4">
<title>Conclusions</title>
<p id="P4">A single dose of DMPA did not have immune-suppressive or pro-inflammatory effects in HIV-infected women on cART. Additional studies need to assess the effect of multiple doses.</p>
</sec>
</div>
</front>
</TEI>
<pmc article-type="research-article">
<pmc-comment>The publisher of this article does not allow downloading of the full text in XML form.</pmc-comment>
<pmc-dir>properties manuscript</pmc-dir>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">100892005</journal-id>
<journal-id journal-id-type="pubmed-jr-id">21821</journal-id>
<journal-id journal-id-type="nlm-ta">J Acquir Immune Defic Syndr</journal-id>
<journal-id journal-id-type="iso-abbrev">J. Acquir. Immune Defic. Syndr.</journal-id>
<journal-title-group>
<journal-title>Journal of acquired immune deficiency syndromes (1999)</journal-title>
</journal-title-group>
<issn pub-type="ppub">1525-4135</issn>
<issn pub-type="epub">1944-7884</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">26413850</article-id>
<article-id pub-id-type="pmc">4712075</article-id>
<article-id pub-id-type="doi">10.1097/QAI.0000000000000850</article-id>
<article-id pub-id-type="manuscript">NIHMS721757</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>EFFECT OF DEPOT MEDOXYPROGESTERONE ACETATE ON IMMUNE FUNCTIONS AND INFLAMMATORY MARKERS OF HIV-INFECTED WOMEN</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Weinberg</surname>
<given-names>Adriana</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Park</surname>
<given-names>Jeong-Gun</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bosch</surname>
<given-names>Ronald</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Cho</surname>
<given-names>Alice</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Livingston</surname>
<given-names>Elizabeth</given-names>
</name>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Aweeka</surname>
<given-names>Fran</given-names>
</name>
<xref ref-type="aff" rid="A4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Cramer</surname>
<given-names>Yoninah</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Watts</surname>
<given-names>D. Heather</given-names>
</name>
<xref ref-type="aff" rid="A5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Luque</surname>
<given-names>Amneris E.</given-names>
</name>
<xref ref-type="aff" rid="A6">6</xref>
<xref rid="FN1" ref-type="author-notes">b</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Cohn</surname>
<given-names>Susan E.</given-names>
</name>
<xref ref-type="aff" rid="A7">7</xref>
<xref rid="FN1" ref-type="author-notes">b</xref>
</contrib>
</contrib-group>
<aff id="A1">
<label>1</label>
University of Colorado Denver Anschutz Medical Center, Aurora, CO</aff>
<aff id="A2">
<label>2</label>
Statistical and Data Analysis Center, Harvard School of Public Health, Boston, MA</aff>
<aff id="A3">
<label>3</label>
Duke University Medical Center, Durham, NC</aff>
<aff id="A4">
<label>4</label>
University of California, San Francisco, CA</aff>
<aff id="A5">
<label>5</label>
Office of the Global AIDS Coordinator and Health Diplomacy, U.S. Department of State, Washington, DC</aff>
<aff id="A6">
<label>6</label>
University of Rochester School of Medicine and Dentistry, Rochester, NY</aff>
<aff id="A7">
<label>7</label>
Northwestern University Feinberg School of Medicine, Chicago, IL</aff>
<author-notes>
<fn id="FN1" fn-type="equal">
<label>b</label>
<p>Equally contributed to this work</p>
</fn>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>29</day>
<month>9</month>
<year>2015</year>
</pub-date>
<pub-date pub-type="ppub">
<day>1</day>
<month>2</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>2</month>
<year>2017</year>
</pub-date>
<volume>71</volume>
<issue>2</issue>
<fpage>137</fpage>
<lpage>145</lpage>
<pmc-comment>elocation-id from pubmed: 10.1097/QAI.0000000000000850</pmc-comment>
<abstract>
<sec id="S1">
<title>Objectives</title>
<p id="P1">Depot medroxyprogesterone acetate (DMPA) was associated with increased HIV transmission and accelerated disease progression in untreated women. The potential underlying mechanisms include immune-modulation. We evaluated the effect of a single DMPA injection on cell-mediated immunity (CMI), T cell activation (Tact), regulation (Treg) and inflammation in HIV-infected women on cART.</p>
</sec>
<sec id="S2">
<title>Methods</title>
<p id="P2">Women with HIV plasma RNA ≤400 c/mL on stable cART received DMPA and had immunologic and MPA measurements at baseline, 4 weeks [peak MPA concentration (Cmax)] and 12 weeks [highest MPA area under the concentration curve (AUC)].</p>
</sec>
<sec id="S3">
<title>Results</title>
<p id="P3">At baseline, among 24 women with median 32 years of age and 622 CD4+ cells/μL, ≥68% had HIV, VZV, PHA and CD3/CD28 CMI measured by lymphocyte proliferation and/or IFNγ/IL2 dual-color fluorospot. CMI did not significantly change after DMPA administration except for a 1.4-fold increase in IL2/IFNγ VZV fluorospot at week 12. Tact decreased after DMPA administration, reaching statistical significance at week 12 for CD4+CD25+%. Treg behaved heterogeneously with an increase in CD8+FOXP3+% at week 4 and a decrease in CD4+IL35+% at week 12. There was a decrease in TGFβ at week 12 and no other changes in plasma biomarkers. Correlation analyses showed that high MPA Cmax and/or AUC were significantly associated with increases of IFNγ HIV ELISPOT, CD4+IL35+% and CD4+TGFβ+% Treg and decreases of plasma IL10 from baseline to weeks 4 and/or 12.</p>
</sec>
<sec id="S4">
<title>Conclusions</title>
<p id="P4">A single dose of DMPA did not have immune-suppressive or pro-inflammatory effects in HIV-infected women on cART. Additional studies need to assess the effect of multiple doses.</p>
</sec>
</abstract>
</article-meta>
</front>
</pmc>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/SidaSubSaharaV1/Data/Pmc/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 0019469 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Pmc/Corpus/biblio.hfd -nk 0019469 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    SidaSubSaharaV1
   |flux=    Pmc
   |étape=   Corpus
   |type=    RBID
   |clé=     
   |texte=   
}}

Wicri

This area was generated with Dilib version V0.6.32.
Data generation: Mon Nov 13 19:31:10 2017. Site generation: Wed Mar 6 19:14:32 2024